Wenxin Zhang, Xiaohui Pan, Yanjun Xu, Hongjie Guo, Mingming Zheng, Xi Chen, Honghai Wu, Fengming Luan, Qiaojun He, Ling Ding, Bo Yang. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ Acta Pharmaceutica Sinica B 13 (2023) 2585-2600J. Acta Pharmaceutica Sinica B, 2023, 13(10): 4337-4337. DOI: 10.1016/j.apsb.2023.07.023
|
Citation:
|
Wenxin Zhang, Xiaohui Pan, Yanjun Xu, Hongjie Guo, Mingming Zheng, Xi Chen, Honghai Wu, Fengming Luan, Qiaojun He, Ling Ding, Bo Yang. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ Acta Pharmaceutica Sinica B 13 (2023) 2585-2600J. Acta Pharmaceutica Sinica B, 2023, 13(10): 4337-4337. DOI: 10.1016/j.apsb.2023.07.023
|
Wenxin Zhang, Xiaohui Pan, Yanjun Xu, Hongjie Guo, Mingming Zheng, Xi Chen, Honghai Wu, Fengming Luan, Qiaojun He, Ling Ding, Bo Yang. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ Acta Pharmaceutica Sinica B 13 (2023) 2585-2600J. Acta Pharmaceutica Sinica B, 2023, 13(10): 4337-4337. DOI: 10.1016/j.apsb.2023.07.023
|
Citation:
|
Wenxin Zhang, Xiaohui Pan, Yanjun Xu, Hongjie Guo, Mingming Zheng, Xi Chen, Honghai Wu, Fengming Luan, Qiaojun He, Ling Ding, Bo Yang. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ Acta Pharmaceutica Sinica B 13 (2023) 2585-2600J. Acta Pharmaceutica Sinica B, 2023, 13(10): 4337-4337. DOI: 10.1016/j.apsb.2023.07.023
|
DownLoad: